ALPS Advisors’s Aprea Therapeutics APRE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q2 | – | Sell |
-1,916
| Closed | -$195K | – | 903 |
|
|
2021
Q1 | $195K | Buy |
1,916
+1
| +0.1% | +$102 | ﹤0.01% | 854 |
|
|
2020
Q4 | $188K | Buy |
1,915
+564
| +42% | +$55.4K | ﹤0.01% | 832 |
|
|
2020
Q3 | $650K | Sell |
1,351
-85
| -6% | -$40.9K | 0.01% | 397 |
|
|
2020
Q2 | $1.11M | Sell |
1,436
-472
| -25% | -$366K | 0.01% | 301 |
|
|
2020
Q1 | $1.33M | Sell |
1,908
-223
| -10% | -$155K | 0.02% | 244 |
|
|
2019
Q4 | $1.96M | Buy |
+2,131
| New | +$1.96M | 0.02% | 229 |
|